Fragile histidine triad (FHIT) gene deletions are among the earliest and most frequent events in carcinogenesis, particularly in carcinogen-exposed tissues. Though FHIT has been established as an authentic tumor suppressor, the mechanism underlying tumor suppression remains opaque. Most experiments designed to clarify FHIT function have analyzed the consequence of re-expressing FHIT in FHIT-negative cells. However, carcinogenesis occurs in cells that transition from FHIT-positive to FHIT-negative. To better understand cancer development, we induced FHIT loss in human bronchial epithelial cells with RNA interference. Because FHIT is a demonstrated target of carcinogens in cigarette smoke, we combined FHIT silencing with cigarette smoke extract (CSE) exposure and measured gene expression consequences by RNA microarray. The data indicate that FHIT loss enhances the expression of a set of oxidative stress response genes after exposure to CSE, including the cytoprotective enzyme heme oxygenase 1 (HMOX1) at the RNA and protein levels. Data are consistent with a mechanism in which Fhit protein is required for accumulation of the transcriptional repressor of HMOX1, Bach1 protein. We posit that by allowing superinduction of oxidative stress response genes, loss of FHIT creates a survival advantage that promotes carcinogenesis.
Introduction
The fragile histidine triad gene (FHIT) is a tumor suppressor that spans the most common fragile site in the human genome, FRA3B. [1] [2] [3] FHIT is constitutively expressed in most tissues, and its loss is associated with a diverse set of malignancies, including lung, stomach, colon, breast and skin carcinomas. 1, [4] [5] [6] [7] [8] [9] [10] [11] Tumors expressing loss of FHIT are typically of epithelial origin, and FHIT has been shown to be a common target of carcinogens, particularly cigarette smoke. [12] [13] [14] [15] Exposure to cigarette smoke is associated with FHIT exon deletion and translocation, as well as hypermethylation of the FHIT promoter with consequent loss of Fhit protein and development of malignancy. 5, 9, 16, 17 Previous work clearly demonstrates the tumor suppressor activity of FHIT. Mice heterozygous at the locus are more susceptible to spontaneous tumor formation. 1, 18 Tumor formation is accelerated by treatment with chemical carcinogens and can be prevented with FHIT gene therapy. 1, 3, 19 Cell culture models show that re-expression of FHIT in FHIT-negative cells induces apoptosis, but the precise molecular mechanisms underlying tumor suppression remain unclear. 4, 6, 20 Recent experiments demonstrate that Fhit deficiency promotes epithelial-mesenchymal transition, that FHIT expression protects genome integrity after carcinogen treatment, and also establish a role for Fhit in mitochondrial biology. [21] [22] [23] [24] [25] [26] [27] Hanahan and Weinberg summarized that cancer cells are marked by the gain of 6 abnormal behaviors. 12, 14, 28 Genome instability and subsequent genetic alterations underlie the acquisition of the hallmarks of cancer, as successive alterations in DNA produce genotypes that confer selective advantages. Frequent loss of FHIT in tumors is well documented. 5, 9, 16, 29 Of equal significance, FHIT inactivation occurs early in the process of carcinogenesis, particularly in lung cancer, 18, 30 suggesting that loss of this gene may facilitate acquisition of the additional alterations required for cell transformation.
Carcinogenesis occurs when cells lose expression of tumor suppressor genes. However, most experiments designed to dissect the mechanism of the FHIT gene were performed by converting FHIT ¡ cells to FHIT C . Here we used RNA interference (RNAi) to model early FHIT loss in bronchial epithelial cells. When FHIT deficient cells were exposed to cigarette smoke, we saw that expression of a set of genes involved in the oxidative stress response was enhanced, including the cytoprotective enzyme heme oxygenase 1 (HMOX1).
HMOX1 expression is induced in response to various insults such as exposure to heavy metals, ultraviolet light, inflammation, and oxidative stress. 19, 31 HMOX1 expression protects cells from dying during acute exposure to stresses, but the mechanisms underlying this function are not fully understood. It has been proposed that the byproducts of Hmox1-catalyzed breakdown of heme, carbon monoxide and bilirubin, underlie cytoprotection by maintaining reactive oxygen species (ROS) homeostasis and promoting a cellular anti-oxidant state. 20, 32 However, expression of a catalytically inactive Hmox1 mutant promotes cell survival after stress as well as the wild type protein, suggesting that Hmox1 cytoprotection functions through an independent, yet to be elucidated mechanism. 28, 33 Early events that occur after Hmox1 expression include increased cell proliferative capacity, 29, 34 decreased cell adhesion, 30, 35 increased migration potential, 31, 35, 36 and evasion of apoptosis. 32, 37 It follows that HMOX1 overexpression is detected in many cancers, including prostate malignancies, melanoma, glioma, adenocarcinoma, and others. 17, 33, 38 Here, we demonstrate that loss of Fhit in bronchial epithelial cells promotes enhanced and sustained induction of Hmox1 in response to cigarette smoke exposure. We investigated the mechanism by which Fhit modulates Hmox1 expression and determined that Fhit loss is associated with decreased expression of a primary transcriptional repressor of HMOX1, Bach1. Thus, Fhit may be required for the normal cellular response to oxidative stress. 
Results

Gene expression changes in response to FHIT knockdown
The mechanism by which FHIT functions as a tumor suppressor has not been fully explained by experiments in which the FHIT gene has been reintroduced to FHIT negative cells. To investigate the hypothesis that Fhit acts as a regulator of gene expression in bronchial epithelial cells, we performed microarray analysis of cells after knocking down FHIT expression with siRNA. HBEC3-TK is an immortalized bronchial epithelial cell line that has been used to study the consequences of gene inactivation in lung cancer. 13, 35 These cells display normal epithelial morphology, are not transformed, have an intact p53 pathway, and have been used by others to study the pathogenesis of lung cancer. 35, 36, 39 We first determined that treatment of HBEC3-TK cells with 2 unique siRNAs robustly silences FHIT expression at both the mRNA and protein level ( Fig. 1 A, B) . Total RNA from treated cells was analyzed by microarray to assess transcriptome changes due to FHIT loss. After restricting the data set to expression changes 1.5-fold with P 0.05 followed by multiple testing correction with a false discovery rate, we observed changes in only 3 genes, suggesting that FHIT loss does not have a large impact on gene expression in this model ( Table 1) .
The FHIT gene, which encompasses the common fragile site at 3p14.2, is a known target Figure 2 . Canonical pathways affected by cigarette smoke exposure. Gene expression changes between cells treated with siControl (48 h) plus 1% CSE (4 h) and cells treated with siControl (48 h) alone were determined by microarray. IPA core analysis was used to generate a list of top biological functions affected by CSE exposure. The significant canonical pathways affected by CSE exposure are represented. x-axis bars represent the [-log(p-value)] of the pathway, calculated by Fisher's exact test. The threshold for this analysis was set to Pvalue0.05. x-axis points (orange) represent the ratio calculated by dividing the number of differentially expressed genes that map to a particular pathway by the total number of genes in that pathway.
of environmental carcinogens including cigarette smoke. Loss of heterozygosity at 3p14 occurs more commonly in smokers than in nonsmokers. 37, 40 Preneoplastic lesions of the lung and cervix show a greater frequency of FHIT loss in smokers than in nonsmokers. 17, 38, 41 Rats exposed to cigarette smoke for short time intervals show a time dependent decrease in FHIT expression at both mRNA and protein levels in bronchial epithelial cells. 15, 42 . Furthermore, peripheral blood samples show that active smokers express fragility at the FHIT locus. 13, [43] [44] [45] Relying on these data, we hypothesized that FHIT plays a role in mediating the cellular response to cigarette smoke. To test this, siRNA-treated HBEC3-TK cells were exposed to 1% CSE for 4 hours prior to RNA extraction and microarray analysis. We first aimed to establish that our CSE treatment protocol impacted gene expression in an expected manner. To do this, we compared gene expression in cells treated with siControl plus 1% CSE to gene expression in cells treated with siControl only. After restricting the dataset to expression changes 1.5-fold with P 0.05 followed by multiple testing correction with a false discovery rate, we observed changes in 378 genes, indicating that the CSE treatment had a strong effect on gene expression. These differentially expressed genes were analyzed with Ingenuity Pathway Analysis (IPA, Ingenuity Systems, www.ingenuity.com) to determine what molecular pathways were altered by CSE treatment. The significant canonical pathways associated with the differentially expressed genes are presented (Fig. 2) . The affected pathways included NRF2-mediated oxidative stress response, glutathione biosynthesis, aryl hydrocarbon receptor signaling, and xenobiotic metabolism signaling, among others. This result is consistent with previous reports that these pathways are affected by exposing cells in culture to cigarette smoke. [46] [47] [48] [49] [50] To assess the combined effect of FHIT knockdown and CSE treatment, we applied the same analysis criteria used for cells that were not treated with CSE to analyze the gene expression consequences of CSE treatment in control and FHIT knockdown cells (Tables 2, 3 ). We determined that a set of genes involved in the cytoprotective oxidative stress response were either only activated in FHIT knockdown cells, or were activated in both FHIT knockdown and control cells, but gene expression was enhanced by FHIT loss. Notably, a subset of the dysregulated genes have annotated roles in the oxidative stress response, suggesting that this pathway may be superinduced in FHIT deficient cells (Fig. 3A) . We validated the gene expression changes of a subset of these genes by quantitative RT-PCR (qRT-PCR) (Fig. 3B) . The data indicate that, in the absence of cigarette smoke, FHIT loss does not significantly alter gene expression. However, a set of genes involved in the cytoprotective oxidative stress response induced by CSE is superinduced by CSE when FHIT is lost. Hmox1 expression is enhanced by FHIT knockdown in CSE stressed cells
One of the CSE-induced genes that is superinduced in FHIT knockdown cells is HMOX1. HMOX1 is a member of a battery of stress response genes whose expression is controlled, in part, by promoter stress response elements. 39, [51] [52] [53] We validated the upregulation of Hmox1 observed in the microarray experiment by qRT-PCR (Fig. 4A) . In the absence of CSE, HMOX1 mRNA is present in amounts approaching the threshold of qRT-PCR detection and the protein is undetectable by western blot (Fig. 4A, B) . CSE treatment induces HMOX1 mRNA and protein expression to readily detectable levels (Fig. 4A, B) . CSE exposure combined with FHIT knockdown markedly increases the level of Hmox1 protein (Fig. 4B) . There are at least 2 heme oxygenase isoforms in mammals, HMOX1 and HMOX2. While HMOX2 is expressed constitutively and confers protection to basal levels of oxidation, HMOX1 is strictly induced in response to stress. 40, 54, 55 Thus, the expression pattern we detected in HBEC3-TK cells is normal. To ascertain that the increase in HMOX1 is not due to an off-target effect of one of the siRNAs, we transfected cells in parallel with a second control and second FHIT-targeting siRNA. In doing so, we confirmed that the increase in HMOX1 is due to FHIT loss (Fig. 4B) . Importantly, the induction of HMOX1 is not affected by the transfection procedure, as indicated by the equivalent results in cells treated with control siRNA and those not treated with siRNA (Fig. 4B) .
These data indicate that in the presence of CSE, FHIT knockdown superinduces HMOX1 expression.
To confirm that the FHIT knockdown-mediated enhancement of HMOX1 induction is not unique to HBEC3-TK cells, we replicated the experiment in 2 unrelated cell lines. We first used an immortalized tracheal airway epitheial cell line, TERT-T106. 20, 41 In these cells, HMOX1 is not detected in the absence of CSE (Fig. 5A) . As observed in HBEC3-TK cells, Hmox1 protein expression is induced by CSE and superinduced when FHIT is knocked down (5A). We then tested if the effect was present in immortalized human foreskin keratinocytes (TERT-HFK) 20, 29, 31, 42, 56 and obtained an equivalent result (Fig. 5B) . These findings indicate that the role of FHIT in limiting Hmox1 expression is not dependent on a specific genetic background or unique cell type. Hmox1 induction occurs earlier and is more sustained in FHIT knockdown cells
To determine whether FHIT knockdown modulates the kinetics of protein accumulation, we exposed siRNA-treated HBEC3-TK cells to CSE for different time intervals and measured the level of Hmox1 by western blot. Hmox1 protein is detected earlier in FHIT knockdown cells and, consistent with previous results, is superinduced at the protein level (Fig. 6A) . Typically, Hmox1 levels increase in response to an acute stress. Once the stress is removed, Hmox1 levels return to baseline. To test if FHIT knockdown affects the rate at which Hmox1 levels decay, we exposed siRNA-treated HBEC3-TK cells to 1% CSE for 4 hours and allowed the cells to recover in fresh media for various time intervals. Loss of FHIT increases expression of Hmox1 at each time point, but the rate of protein decay was not altered (Fig. 6B) .
Mechanism of Hmox1 superinduction in response to FHIT loss
Previous studies have demonstrated that FHIT expression affects calcium signaling, attenuates NF-kB signaling, and promotes phosphorylation and activation of AKT. [43] [44] [45] 57 Notably, modulation of these pathways has also been demonstrated to affect HMOX1 expression. [51] [52] [53] [58] [59] [60] For this reason, we asked whether the superinduction of HMOX1 seen after FHIT knockdown might be mediated through one or more of these pathways. However, we found that these pathways do not contribute to upregulation of HMOX1 in our model (Figs. 7-10 ).
Upon excluding these pathways, we analyzed the regulation of the wellcharacterized Bach1-Nrf2 oxidative stress response axis. Nrf2 and Bach1 are canonical regulators of HMOX1 transcription that bind DNA cis-elements to activate or repress target gene transcription, respectively. 54, 55, 61 We found that Nrf2 mRNA and protein levels are unchanged in response to FHIT knockdown in both CSE treated and untreated cells (Fig. 11A and B) . Additionally, while knockdown of NFE2L2, the gene that encodes Nrf2, blunts the induction of HMOX1 in response to stress, simultaneous knockdown of FHIT and NFE2L2 still yields a superinduction of HMOX1 (Fig. 11C) . These data indicate that the ability of FHIT to dampen HMOX1 expression does not require Nrf2.
As with Nrf2, BACH1 mRNA levels were not dependent on FHIT expression or the application of CSE (Fig. 12A) . In addition, Bach1 protein levels were unchanged in response to FHIT knockdown in the absence of stress (Fig. 12B) . However, two observations about Bach1 protein were made in CSE-treated cells. First, CSE treatment produced a slowly migrating species of Bach1 (Fig. 12B) . This species was confirmed to be Bach1 by siRNA knockdown in an independent experiment (Fig. 12C) . Second, the total level of Bach1 protein was decreased in FHIT knockdown cells. Quantification of the results of multiple experiments indicates that FHIT knockdown combined with CSE stress results in a »40% reduction in Bach1 protein (Fig. 12D) . To test whether a reduction in Bach1 is sufficient to induce Hmox1 protein, we titrated BACH1 siRNA into HBEC3 cells and saw a clear and inverse relationship between Bach1 and Hmox1 levels ( Fig. 13A and B) . Interestingly, we also note that the levels of Fhit and Bach1 protein are inversely correlated. Taken together, the data indicate that the superinduction of HMOX1 in FHIT knockdown cells may be mediated through decreased stability or translation of Bach1 protein in cells that have both lost FHIT and are stressed with cigarette smoke.
Discussion
This work provides evidence of a role for FHIT in the cellular response to oxidative stress, demonstrating that when FHIT is depleted from cells exposed to cigarette smoke, the induction of a subset of oxidative stress response genes, including HMOX1, is enhanced. Several studies have illustrated a key role for HMOX1 in promoting cell survival during inflammation, and HMOX1 expression has multiple functions in smoking-mediated lung cancers. 20, [62] [63] [64] [65] Because HMOX1 promotes cell proliferation and increases resistance to oxidative stress, overexpression of HMOX1 imparts a selective advantage to cells in the early stages of carcinogenesis and correlates with resistance to many chemotherapeutics in malignancy. 20, 29, 31, 56 Thus, our data link loss of Fhit to a key pathway in the establishment and maintenance of the malignant state.
A multitude of signaling pathways impact the expression of HMOX1. We investigated several implicated pathways and identified a relationship between loss of Fhit and reduced protein levels of Bach1. The Bach1 transcription factor suppresses the expression of a battery of stress response genes. In the absence of stress, Bach1 binds to DNA antioxidant response elements (AREs) and strongly represses gene transcription. Upon application of stress, Bach1 is released from DNA and is exported to the cytoplasm where it is targeted for ubiquitylation and proteasome-mediated degradation. 57 Concomitant with Bach1 export, the activating transcription factor Nrf2 translocates into the nucleus and occupies AREs previously bound by Bach1, promoting a coordinated induction of stress response genes. Aberrant transcriptional activity of Bach1 and Nrf2 underlie several diseases, including many cancers. Our study suggests that FHIT knockdown decreases protein levels of Bach1, which is sufficient to enhance expression of HMOX1 in epithelial cells. An outstanding question is how FHIT loss leads to decreased Bach1 protein levels. Bach1 is targeted for ubiquitylation by the E3 ligase HOIL-1 (RBCK1), but to date we have not seen differences in HOIL-1 expression levels in FHIT knockdown relative to control treated HBEC3-TK cells, nor have we seen differences in HOIL-1 splice variants (unpublished data). Additionally, we have not detected a difference in nuclear export of Bach1 that depends on Fhit expression (unpublished results). Importantly, it is clear that BACH1 mRNA levels are not affected by FHIT loss, so we hypothesize that Fhit modulates the stability or translation of Bach1 protein. Strikingly, the inverse relationship between levels of Fhit and Bach1 protein implies that the FHIT gene may be a target of repression by Bach1. This finding is interesting as it suggests that the proteins participate in a regulatory feedback loop during control of the oxidative stress response in cancer-promoting environments.
Substantive evidence implicates Fhit in tumor suppression but the precise mechanism underlying the function has not been elucidated. Fhit protein is a dimeric histidine triad protein that binds and hydrolyzes diadenosine triphosphate (ApppA) and related nucleotides. [58] [59] [60] ApppA, a product of reactions catalyzed by tRNA synthetases and other enzymes, has been proposed to have several intracellular functions including signaling stress responses. 61 Indeed, the intracellular concentration of ApppA increases in cells exposed to oxidative stressors. [62] [63] [64] [65] Because mutation of the Fhit enzyme active site histidine residue greatly retards ApppA cleavage without a strong effect on ApppA binding or proapoptotic activity After knockdown, cells were exposed to 1% CSE for 4 hours. Hmox1 protein abundance was assessed by western blot. The data show that Hmox1 expression is enhanced by FHIT knockdown in these cells, demonstrating that the role of FHIT in modulating Hmox1 expression does not require a specific genetic background.
www.landesbioscience.comin a reexpression assay, it has been argued that the Fhit-ApppA complex may mediate the function of Fhit. 2, [66] [67] [68] While these experiments were valuable in dissection of the amino acids and nucleotide interactions linked to Fhit function, the Fhit re-expression system may have biased the result to an apoptotic pathway. In contrast, our model recapitulates the process of carcinogenesis by analyzing the cellular consequence of FHIT loss. It will be interesting to probe the relationship between CSE and induction of ApppA and related nucleotides in the control of oxidative stress genes.
Since its discovery in 1996, hundreds of papers have described the FHIT gene. Many of these studies attempt to dissect the mechanism of Fhit-mediated tumor suppression, but they present disparate explanations for the phenomenon, and a unifying theory has proved to be elusive. Our proposal that Fhit limits cell growth by attenuating the oxidative stress response is supported by independently published studies that connect Fhit function with the accumulation of intracellular ROS. For example, FHIT-deficient bone marrow cells (BMC) have lower levels of ROS after hydroquinone challenge. A reduction in intracellular levels of ROS are detected in FHIT negative BMCs relative to wild-type, and this reduction in ROS accumulation is linked to failure to induce apoptosis as the phenotype is reversed with application of the antioxidant N-acetyl-L-cysteine. 1, 5, [7] [8] [9] 69 Several studies that connect Fhit expression to increased sensitivity to anti-cancer drugs may also serve to substantiate the link between Fhit function and oxidative stress. Re-expression of Fhit in Fhit-negative cancerderived cell lines increases sensitivity to mitomycin C (MMC), camptothecin (CPT), and cisplatin. 13, 15, 70, 71 While the canonical role of each drug involves modulation of DNA topography to induce DNA damage, 16, 17, [72] [73] [74] each agent also effects ROS production, and the production of ROS has been demonstrated to underlie the toxic effect of each compound.
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Resupplying FHIT to FHIT-negative cells increases cell death after MMC, CPT, and cisplatin treatments, but this phenomenon has not explained mechanistically. Thus the ability of Fhit to dampen expression of antioxidant response genes may not only explain the effects of FHIT gene loss in this study but the effect of FHIT reexpression in many studies.
Materials and Methods
Cell culture HBEC3-TK bronchial epithelial cells were a kind gift from Dr. John Minna (UT Southwestern). TERT-HFK human foreskin keratinocytes and TERT-T106 tracheal airway epithelial cells were generous gifts of Dr. Aloysius Klingelhutz (University of Iowa). Cells were cultured on bovine collagen coated plastic dishes (Sigma, Cat #C4243). Cells were maintained in Keratinocyte Serum Free Media (KSFM) supplemented with BPE (12.5 g/ml) and EGF (5.0 ng/ml) (Gibco Cat #17005-075). Cells were grown in humidified 37 C, 5% CO 2 incubators.
siRNA transfection Cells were seeded at densities of 400,000 cells/plate (10 cm dishes), 125,000 cells per well (6 well dishes), or 30,000 cells/ well (12 well dishes). After overnight incubation, cells were transfected with 15 nM siRNA and Lipofectamine RNAiMax (Invitrogen, Carlsbad CA) according to the manufacturer's protocol. siRNAs were obtained from commercial vendors. FHIT siRNA-1 (Cat #4390843), FHIT siRNA-2 (Cat #AM16706), Control siRNA-1 (Cat #4390843), and Control siRNA-2 (Cat #4390846) were purchased from Ambion (Life Technologies). BACH1 siRNA (Cat # HSC.RNAI.N001186.12.1) and NFE2L2 siRNA (Cat #HSC.RNAI.N001145412.12) were purchased from IDT (Coralville, IA). After 4.5 hours of siRNA incubation, transfection media were replaced with fresh KSFM. Cells were incubated for 48 hours.
Cigarette smoke extract preparation
Research grade cigarettes were purchased from the University of Kentucky. After removing the filter, the cigarette was www.landesbioscience.comcombusted and smoke extracted into 10 ml of KSFM, as described previously. 15, 34 This preparation was termed "100% CSE." The extract was filtered though a 0.22 mm pore membrane (Millipore Cat #SCGP00525). CSE was diluted to 1% in KSFM and added to cells in culture for the indicated times. CSE treated cells were incubated separately from non-CSE treated cells.
RNA extraction, cDNA synthesis, and RT-PCR analysis Total RNA was extracted from cells using the RNeasy Mini kit (Qiagen, Cat #74104) after homogenizing cells with Qiashredder spin columns (Qiagen, Cat #79654). RNA was DNase treated with the Turbo DNA-free kit (Ambion, Cat #AM1907). 500 ng total RNA was reverse transcribed with the iScript cDNA synthesis kit (BioRad, Cat #170-8890) or 1.5 mg total RNA was reverse transcribed with the High Capacity cDNA synthesis kit (Applied Biosystems, Cat #4368814). RT-PCR was performed with iQ SYBR Green Supermix (BioRad, Cat #170-880) and designed primers or with TaqMan Gene Expression Master Mix (Applied Biosystems, Cat #4369016) and PrimeTime nuclease primer/probe assays (IDT). Nuclease assays used in this study are: NFE2L2, IDT Catalog Hs.PT.49a.36704, GAPDH, IDT Catalog Hs.PT.47.1164609, FHIT, IDT Catalog Hs. PT.47.3317107, and HMOX1, IDT Catalog Hs. PT.53a.22439609. Primers used in SYBR Green assays are listed in 5'-3' direction as follows: AKR1B10 -GCCACAGGGATT-CAAGTCT and CTTTCACCAGCCCCTCATC; AKR1C1 -GCCGTGGAGAAGTGTAAAGATG and CTGGTTGAAG-TAAGGATGACATTC; AKR1C2 -TAAAGCCAGGTGAG-GAAGTG and CTGTGGTTGAAGTTGGACAC; AKR1C3 -AACAAGCCAGGACTCAAGTAC and CAGAGCACTATAGGCAACCAGl NQO1 -CCGCAGACCTTGTGATATT-CC and ACTCGCTCAAACCAGCCTTTCAGA; GPX2 -GCTTCCCTTGCAACCAATTTG and TTCTGCCCATTC-ACCTCAC; SERPINB2 -CAGTAGACTTCCTAGAATGTGCAG and AAGTAGACAGCATTCACCAGG; SRXN1 -CAAGGTGCA-GAGCCTCG and CTTTGATCCAGAGGACATCGA; BACH1 -TCTTGAATCAGAAATTGAGAA-GCTG and TGGCAAAGTCCA-GTTAGGTTCTGCT; GAPDH -ACATCGCTCAGACACCATG and TGTAGTTGAGGTCAATG-AAGGG.
Immunoblotting Cells were suspended in ice-cold RIPA buffer (50 mM Tris-Cl (pH 8), 1% NP-40, 0.5% Na deoxycholate, 0.1% SDS, 150 mM NaCl, 5 mM EDTA) supplemented with protease inhibitors (Roche Cat #11836170001) and phosphatase inhibitors (Roche Cat #04906845001). Cells were lysed on ice for 20 minutes before clarifying (4 C, 13 K rpm, 10 minutes). Protein content was quantified with the BCA Protein Assay (Pierce Cat #23225). Equivalent amounts of protein were reduced with 50 mM DTT, denatured with LDS, heated, and loaded on NuPage 4-12% Bis-Tris gels (Invitrogen) and electrophoresed in 1x MOPS buffer. Protein gels were transferred to nitrocellulose membranes, which were blocked with 5% milk. Primary antibodies were incubated with membranes overnight at 4 C. Secondary antibody incubations were performed at room temperature for 30 minutes. Blots were developed with ECL -SuperSignal West Pico (Pierce), Supersignal West Femto (Pierce), or Quantum (Advansta) reagents. Images were collected with GE ImageQuant LAS4000 and quantification performed with ImageQuant TL7.0 software (GE). Fhit antibody was obtained from Millipore (Cat #07-172). Bach1 (Cat #sc-14700), Nrf2 (Cat #sc-365949), and HRP conjugated donkey-anti-goat (Cat #sc-2020) antibodies were purchased from Santa Cruz Biotechnology. Hmox1 (Cat #4643), b-tubulin (Cat #2128), Gapdh (Cat #5174), AKT (Cat #9272), phosphoAKT (Cat #4060), HRP-anti-mouse (Cat #7076), and HRP-anti-rabbit (Cat #7074) antibodies were purchased from Cell Signaling Technologies. b-actin (Cat #A2066) antibody was obtained from Sigma. Figure 11 . FHIT-mediated repression of HMOX1 does not require Nrf2. HBEC3-TK cells were transfected with control, FHIT, or NFE2L2 siRNAs. After transfection, cells were either treated for 4 hours with 1% CSE or left untreated. (A) NFE2L2 (Nrf2) expression was quantified by qRT-PCR. FHIT knockdown does not effect NFE2L2 mRNA levels before or after CSE treatment. The data represent the results of three independent experiments. (B) Nrf2 protein abundance was assessed by protein gel blot. Nrf2 migrates at the expected molecular weight in both CSE and non-CSE treated samples. A slow migrating species of Nrf2 (» 75 kD) appears in CSE treated cells. Treatment with NFE2L2 siRNA confirms both isoforms as Nrf2. FHIT knockdown has no effect on Nrf2 protein abundance. (C) RNA was collected from cells transfected with control, FHIT siRNA, or NFE2L2 siRNA alone, or FHIT and NFE2L2 siRNA together. Knockdown of NFE2L2 blunts the induction of HMOX1 after CSE exposure. Concurrent knockdown of FHIT and NFE2L2 yields a superinduction of HMOX1 to a magnitude similar to that when only FHIT is depleted. Data represent the results of three independent experiments. www.landesbioscience.com
Treatment with inhibitors
Stock solutions of inhibitors were prepared in anyhydrous DMSO, aliquoted, and stored at ¡20 C. Compounds were diluted to working concentrations in KSFM immediately before use. The PI3K inhibitor LY294002 was purchased from Cell Signaling Technologies (Cat #9901). The IKK2 inhibitor SC-514 was purchased from Cayman Chemical (Cat #10010267). The cell permeable Ca 2C chelator BAPTA-AM was purchased from Invitrogen (Cat #B-6769).
DNA microarray
Microarray hybridizations were performed at the University of Iowa DNA Facility. Briefly, 50 ng total RNA was converted to single primer isothermal amplification (SPIA) cDNA using the WT-Ovation Pico RNA Amplification System, v1 (NuGEN Technologies, San Carlos, CA, Cat #3300) according to the manufacturer's protocol. The amplified cDNA product was purified through a QIAGEN MinElute Reaction Cleanup column (QIAGEN Cat #28204) according to modifications from NuGEN. DNA product (4.0 mg) was then used to generate sense target cDNA using C for 18 h with 60 rpm rotation in an Affymetrix Model 640 Genechip Hybridization Oven. Following hybridization, the arrays were washed, stained with streptavidin-phycoerythrin (Molecular Probes, Inc., Eugene, OR) and with antistreptavidin antibody (Vector Laboratories, Inc., Burlingame, CA) using the Affymetrix Model 450 Fluidics Station. Arrays were scanned with the Affymetrix Model 3000 scanner (7 G upgrade) and data were collected using the GeneChip operating software v 1.4.
Microarray data analysis
The array data were analyzed for significant changes in expression using Partek Genomics Suite Software (Partek, Inc.). Three biological replicates for each treatment were processed and analyzed. Briefly, the expression value estimates generated by microarray scanners were normalized using the robust multi-array averaging algorithm. Analysis of variation followed by multiple testing correction using the false-discovery rate was used to assess significant changes in expression profile between samples. Expression data for siControl C/¡ CSE were analyzed with Ingenuity Pathway Analysis (IPA, Ingenuity Systems, www. ingenuity.com). The IPA Canonical Pathways Analysis tool was used to identify the pathways from the IPA Library of Canonical Pathways that were most significant in the data. A dataset containing gene identifiers with expression fold change and associated p-value was uploaded to the application. The data were then limited to fold change C/¡ 1.5 and p-value 0.05. A core analysis was performed to identify gene function and a canonical pathway analysis was used to identify the pathways to which the genes mapped. Significance is measured within IPA by 2 means: 1.) Determination of a ratio calculated by dividing the number of differentially expressed genes that map to a particular pathway by the total number of genes in that pathway; 2.) Calculation of a p-value by Fisher's exact test to determine the probability that the association between the genes in the data set and the canonical pathway can be explained by chance. 
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